Jugurtha Berkenou

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Hyperparathyroidism after 3 years of burosumab in children affected with X-linked hypophosphatemia.

Hyperparathyroidism after 3 years of burosumab in children affected with X-linked hypophosphatemia.

Journal: European journal of endocrinology

Published: April 27, 2026

Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatment.

Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatment.

Journal: European journal of endocrinology

Published: January 09, 2026

Clinical picture of early infancy PTH resistance syndromes: is it time to improve diagnostic criteria?

Clinical picture of early infancy PTH resistance syndromes: is it time to improve diagnostic criteria?

Journal: The Journal of clinical endocrinology and metabolism

Published: August 01, 2025

Burosumab prevents further height deficit in toddlers affected by XLH.

Burosumab prevents further height deficit in toddlers affected by XLH.

Journal: Endocrine connections

Published: July 15, 2025

Prevalence of hearing loss in pseudohypoparathyroidism.

Prevalence of hearing loss in pseudohypoparathyroidism.

Journal: Orphanet journal of rare diseases

Published: April 29, 2024

Characterization of Digestive Manifestations in Patients with Impaired PTH/PTHrP Signaling Disorder/Pseudohypoparathyroidism.

Characterization of Digestive Manifestations in Patients with Impaired PTH/PTHrP Signaling Disorder/Pseudohypoparathyroidism.

Journal: Hormone research in paediatrics

Published: January 09, 2024

High Prevalence of Hypercalcitoninemia in a Large Cohort of Adult and Pediatric Patients With PTH Resistance Syndromes.

High Prevalence of Hypercalcitoninemia in a Large Cohort of Adult and Pediatric Patients With PTH Resistance Syndromes.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 22, 2023

Adult height improved over decades in patients with X-linked hypophosphatemia: a cohort study.

Adult height improved over decades in patients with X-linked hypophosphatemia: a cohort study.

Journal: European journal of endocrinology

Published: April 21, 2023

Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations.

Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations.

Journal: European journal of endocrinology

Published: March 29, 2023

Neonatal and Early Infancy Features of Patients With Inactivating PTH/PTHrP Signaling Disorders/Pseudohypoparathyroidism.

Neonatal and Early Infancy Features of Patients With Inactivating PTH/PTHrP Signaling Disorders/Pseudohypoparathyroidism.

Journal: The Journal of clinical endocrinology and metabolism

Published: January 16, 2023

Combined gait analysis and radiologic examination in children with X-linked hypophosphatemia.

Combined gait analysis and radiologic examination in children with X-linked hypophosphatemia.

Journal: Clinical biomechanics (Bristol, Avon)

Published: November 28, 2022

Growth patterns and outcomes of growth hormone therapy in patients with acrodysostosis.

Growth patterns and outcomes of growth hormone therapy in patients with acrodysostosis.

Journal: Journal of endocrinological investigation

Published: September 08, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026